Glucotrack (GCTK) Enterprise Value (2013 - 2026)

Glucotrack (GCTK) has reported Enterprise Value for 14 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 89.13% year-over-year to -$1.0 million; the trailing twelve-month figure through Jun 2026 stood at -$1.0 million (up 89.13% YoY), and the FY2025 full-year result was -$7.2 million, down 32.46% from the prior year.
• Enterprise Value climbed to -$1.0 million in Q2 2026 per GCTK's latest filing, from -$7.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at $582332.0 in Q3 2024 and bottomed at -$9.4 million in Q2 2025.
• Historically, Enterprise Value has averaged -$3.7 million across 5 years, with a median of -$1.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 108.93% in 2024, then sank 1729.47% in 2025.
• Over 5 years, Enterprise Value stood at -$856880.0 in 2022, then plunged by 381.67% to -$4.1 million in 2023, then sank by 32.11% to -$5.5 million in 2024, then plunged by 32.46% to -$7.2 million in 2025, then jumped by 85.92% to -$1.0 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$1.0 million, -$7.2 million, and -$7.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.